Clinical Trial Update: Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract(YY-162)in Children With ADHD [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing a combination of Ginkgo extract and Ginseng extract (YY-162) for ADHD in children has completed, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Ginkgo extract and Ginseng extract (YY-162) combination

Snippet

Sponsor: Yuyu Pharma, Inc. | Conditions: Mental Disorders | Phase 3 | Status: COMPLETED